JP7012724B2 - 腎臓透析を受けている患者のための食餌性多量／微量栄養補給剤 - Google Patents

腎臓透析を受けている患者のための食餌性多量／微量栄養補給剤 Download PDF

Info

Publication number
JP7012724B2
JP7012724B2 JP2019531865A JP2019531865A JP7012724B2 JP 7012724 B2 JP7012724 B2 JP 7012724B2 JP 2019531865 A JP2019531865 A JP 2019531865A JP 2019531865 A JP2019531865 A JP 2019531865A JP 7012724 B2 JP7012724 B2 JP 7012724B2
Authority
JP
Japan
Prior art keywords
amount
unit dose
per unit
vitamin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019531865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019532098A5 (enExample
JP2019532098A (ja
Inventor
ダブドゥブ，アティフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2017/048126 external-priority patent/WO2018039297A1/en
Publication of JP2019532098A publication Critical patent/JP2019532098A/ja
Publication of JP2019532098A5 publication Critical patent/JP2019532098A5/ja
Application granted granted Critical
Publication of JP7012724B2 publication Critical patent/JP7012724B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2019531865A 2016-08-26 2017-08-23 腎臓透析を受けている患者のための食餌性多量／微量栄養補給剤 Active JP7012724B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662379872P 2016-08-26 2016-08-26
US62/379,872 2016-08-26
SE1651259-2 2016-09-23
SE1651259A SE542106C2 (en) 2016-08-26 2016-09-23 Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
PCT/US2017/048126 WO2018039297A1 (en) 2016-08-26 2017-08-23 Dietary macro/micronutritional supplement for patients undergoing kidney dialysis

Publications (3)

Publication Number Publication Date
JP2019532098A JP2019532098A (ja) 2019-11-07
JP2019532098A5 JP2019532098A5 (enExample) 2020-10-01
JP7012724B2 true JP7012724B2 (ja) 2022-02-14

Family

ID=61685089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019531865A Active JP7012724B2 (ja) 2016-08-26 2017-08-23 腎臓透析を受けている患者のための食餌性多量／微量栄養補給剤

Country Status (4)

Country Link
US (2) US11077085B2 (enExample)
EP (1) EP3503745B1 (enExample)
JP (1) JP7012724B2 (enExample)
SE (1) SE542106C2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7627100B2 (ja) * 2020-09-30 2025-02-05 森永乳業株式会社 貧血の予防又は治療用組成物、血中ヘモグロビン濃度の増加又は低下予防用組成物、及び血中赤血球数の増加又は低下予防用組成物
WO2023215815A1 (en) * 2022-05-05 2023-11-09 Dabdoub Atif Dietary macro/micronutritional compositions and applications thereof
FR3140243A1 (fr) * 2022-09-30 2024-04-05 Periop One Complément alimentaire

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513370A (ja) 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
US20020155163A1 (en) 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
WO2003032751A1 (en) 2001-10-18 2003-04-24 Aldo Fassi Alkanoyl l-carnitine metal salts and dietary supplements
JP2003521501A (ja) 2000-02-04 2003-07-15 アボット・ラボラトリーズ 栄養を供給し耐性を改善するための改善された小児科学的製剤および方法
US20040082536A1 (en) 2002-10-25 2004-04-29 Cooper Kenneth H. Multi-vitamin and mineral supplement
US20050191386A1 (en) 2004-02-26 2005-09-01 Adams Jason P. Nutritional supplement compositions and methods
JP2006028051A (ja) 2004-07-14 2006-02-02 Lion Corp 起床時疲労感改善剤、起床時疲労感改善用組成物、及びこれらを含む起床時疲労感改善用飲食物
JP2007244325A (ja) 2006-03-17 2007-09-27 Daicho Kikaku:Kk 新しい健康食品
JP2008516948A (ja) 2004-10-15 2008-05-22 イブレット・ラボラトリーズ・インコーポレーテッド 腎臓患者における栄養欠乏の補充のための方法及び組成物
JP2008247748A (ja) 2007-03-29 2008-10-16 En Otsuka Pharmaceutical Co Ltd 透析患者用栄養組成物
US20080317725A1 (en) 2007-06-20 2008-12-25 Baum Seth J Compositions and methods of treating chronic kidney disease
JP2009520824A (ja) 2005-12-20 2009-05-28 セネストラ エルエルシー オメガ３脂肪酸製剤
WO2009087988A1 (ja) 2008-01-09 2009-07-16 Nutri Co., Ltd. がん化学療法時に起こる酸化ストレス及び／又は副作用の軽減あるいはがん化学療法時の栄養状態を改善するための組成物
JP2009203219A (ja) 2007-10-12 2009-09-10 Asahi Kasei Pharma Kk ＣｏＱ１０含有栄養組成物
JP2010505409A (ja) 2006-10-06 2010-02-25 ジャンルカ メック， タンパク質活性化因子を含む栄養補助食品
WO2010077878A1 (en) 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
JP2011105632A (ja) 2009-11-16 2011-06-02 Api Co Ltd グルタミン含有栄養組成物
US20110280851A1 (en) 2010-05-12 2011-11-17 Herzlinger Alexander S Compositions Comprising Cranberry Extract and Methods of Use Thereof
JP2012019691A (ja) 2010-06-17 2012-02-02 Morinaga Milk Ind Co Ltd 腎疾患患者用経口栄養組成物
JP2012214435A (ja) 2011-03-29 2012-11-08 Nipro Corp 経口アミノ酸組成物
JP2013516464A (ja) 2010-01-04 2013-05-13 ペンテック ヘルス， インコーポレイテッド 栄養組成物およびその使用方法
WO2013072767A1 (en) 2011-11-18 2013-05-23 Pronova Biopharma Norge As Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
US20140107223A1 (en) 2012-10-12 2014-04-17 Whitehill Oral Technologies, Inc. Topical ubiquinol supplement skin care compositions
JP2014532032A (ja) 2011-04-05 2014-12-04 ロンザ・リミテッド 疲労を減少させるためまたは予防するためおよび認知機能を改善するためのｌ−カルニチン、その塩および誘導体の使用
JP2015524477A (ja) 2012-08-07 2015-08-24 バック・インスティテュート・フォー・リサーチ・オン・エイジング 神経機能を改善するための多成分製剤
JP2015209398A (ja) 2014-04-25 2015-11-24 ユーハ味覚糖株式会社 高吸収型ユビキノール製剤
CN105519961A (zh) 2014-09-29 2016-04-27 华仁药业股份有限公司 一种用于透析患者的肠内营养制剂及其制备方法
US20160199337A1 (en) 2013-09-05 2016-07-14 Children's Healthcare Of Atlanta, Inc. Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992282A (en) * 1989-05-08 1991-02-12 The Procter & Gamble Company Stable nutritional vitamin and mineral supplemented beverage
EP0514451B1 (en) * 1990-02-05 1997-01-15 LifeScience Corporation Dietary supplements comprising vitamins and minerals
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
US5714168A (en) * 1996-12-11 1998-02-03 Basf Corporation Method for increasing flowability of spray dried vitamin powders having low vitamin concentrations
JP2000264844A (ja) * 1999-01-11 2000-09-26 Otsuka Pharmaceut Factory Inc 腎疾患患者用栄養組成物
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
US6995166B1 (en) 2000-09-27 2006-02-07 Everett Laboratories, Inc. Method and composition for supplementation of nutritional deficiencies in renal patients
US6855733B2 (en) * 2001-01-24 2005-02-15 Soft Gel Technologies, Inc. Formulation and manufacturing process for coenzyme Q10 soft gel capsules
US7635469B2 (en) 2002-08-28 2009-12-22 Premier Micronutrient Corporation Micronutrient formulations for hearing health
US8617617B2 (en) * 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US20040137080A1 (en) * 2003-01-13 2004-07-15 Cremisi Henry D. Multivitamin regimen for renal patients
EP1716766A1 (en) * 2003-07-21 2006-11-02 Unilever N.V. Aiding of cognitive function
WO2005123108A2 (en) 2004-06-09 2005-12-29 William Feinstein Advanced vitamins and protein based nutritional supplements
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
EP1874130A4 (en) * 2005-04-19 2009-04-29 Hills Pet Nutrition Inc METHOD AND COMPOSITIONS FOR PREVENTING AND TREATING NURSE DISEASES
US20060292217A1 (en) * 2005-06-03 2006-12-28 Schmidt Robbin D Nutritional supplement and soft gelatin capsule delivery system
JP2007001922A (ja) * 2005-06-23 2007-01-11 Asahi Kasei Pharma Kk 透析患者における腎疾患改善剤、又は機能性食品
TW200735863A (en) * 2006-01-13 2007-10-01 Elixirin Corp Dietary compositions for enhancing metabolism and reducing reactive oxygen species
JP2010270095A (ja) * 2008-05-30 2010-12-02 Yamaha Motor Co Ltd 認知行動能力向上剤
US8680053B2 (en) * 2008-07-09 2014-03-25 Quercegen Pharmaceuticals Llc Improving renal function with quercetin-containing compositions
US20100047363A1 (en) 2008-11-07 2010-02-25 John Wigneswaran Nutritional supplement for patients with chronic kidney disease
US9176146B2 (en) * 2009-08-03 2015-11-03 Theta Biomedical Consulting & Development Co., Inc. Methods of treating autism spectrum disorders and compositions for same
US8501248B1 (en) * 2010-11-02 2013-08-06 Seven Consulting, Inc. Botanical composition and method for treating pain and discomfort of various conditions
CA2855469A1 (en) 2011-04-22 2012-10-26 Paul Joseph FAERSTEIN Compositions and methods for nutritional supplementation
US8183227B1 (en) * 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
WO2013033618A1 (en) * 2011-09-02 2013-03-07 Arctic Nutrition As Lipid compositions with high dha content
US9775855B2 (en) * 2011-09-14 2017-10-03 Thomas J. Lewis Compositions comprising macrolide and tetracycline and their uses
BE1021010B1 (nl) 2013-03-29 2014-12-17 Omega Pharma Innovation & Development Nv Kit met meerdere voedingssupplementen en werkwijze voor het samenstellen ervan.
MX2016004487A (es) * 2013-10-30 2016-11-10 Banner Life Sciences Llc Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
EP3157936B1 (en) 2014-06-18 2018-10-17 Thetis Pharmaceuticals LLC Mineral amino-acid complexes of active agents
US20160089343A1 (en) 2014-09-29 2016-03-31 LSU Health Sciences Center Shreveport Microsized curcumin compositions
US20170128486A1 (en) * 2014-11-12 2017-05-11 ImmunoL0G1C R&D Inc. Consumable compositions and uses thereof for alleviating undesirable physiological effects systems
US9446100B2 (en) 2015-02-13 2016-09-20 Eastern Vision Limited Dietary supplements and formulations
WO2018039297A1 (en) 2016-08-26 2018-03-01 Dabdoub Atif Dietary macro/micronutritional supplement for patients undergoing kidney dialysis

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513370A (ja) 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
US20020155163A1 (en) 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
JP2003521501A (ja) 2000-02-04 2003-07-15 アボット・ラボラトリーズ 栄養を供給し耐性を改善するための改善された小児科学的製剤および方法
WO2003032751A1 (en) 2001-10-18 2003-04-24 Aldo Fassi Alkanoyl l-carnitine metal salts and dietary supplements
US20040082536A1 (en) 2002-10-25 2004-04-29 Cooper Kenneth H. Multi-vitamin and mineral supplement
US20050191386A1 (en) 2004-02-26 2005-09-01 Adams Jason P. Nutritional supplement compositions and methods
JP2006028051A (ja) 2004-07-14 2006-02-02 Lion Corp 起床時疲労感改善剤、起床時疲労感改善用組成物、及びこれらを含む起床時疲労感改善用飲食物
JP2008516948A (ja) 2004-10-15 2008-05-22 イブレット・ラボラトリーズ・インコーポレーテッド 腎臓患者における栄養欠乏の補充のための方法及び組成物
JP2009520824A (ja) 2005-12-20 2009-05-28 セネストラ エルエルシー オメガ３脂肪酸製剤
JP2007244325A (ja) 2006-03-17 2007-09-27 Daicho Kikaku:Kk 新しい健康食品
JP2010505409A (ja) 2006-10-06 2010-02-25 ジャンルカ メック， タンパク質活性化因子を含む栄養補助食品
JP2008247748A (ja) 2007-03-29 2008-10-16 En Otsuka Pharmaceutical Co Ltd 透析患者用栄養組成物
US20080317725A1 (en) 2007-06-20 2008-12-25 Baum Seth J Compositions and methods of treating chronic kidney disease
JP2009203219A (ja) 2007-10-12 2009-09-10 Asahi Kasei Pharma Kk ＣｏＱ１０含有栄養組成物
WO2009087988A1 (ja) 2008-01-09 2009-07-16 Nutri Co., Ltd. がん化学療法時に起こる酸化ストレス及び／又は副作用の軽減あるいはがん化学療法時の栄養状態を改善するための組成物
WO2010077878A1 (en) 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
JP2011105632A (ja) 2009-11-16 2011-06-02 Api Co Ltd グルタミン含有栄養組成物
JP2013516464A (ja) 2010-01-04 2013-05-13 ペンテック ヘルス， インコーポレイテッド 栄養組成物およびその使用方法
US20110280851A1 (en) 2010-05-12 2011-11-17 Herzlinger Alexander S Compositions Comprising Cranberry Extract and Methods of Use Thereof
JP2012019691A (ja) 2010-06-17 2012-02-02 Morinaga Milk Ind Co Ltd 腎疾患患者用経口栄養組成物
JP2012214435A (ja) 2011-03-29 2012-11-08 Nipro Corp 経口アミノ酸組成物
JP2014532032A (ja) 2011-04-05 2014-12-04 ロンザ・リミテッド 疲労を減少させるためまたは予防するためおよび認知機能を改善するためのｌ−カルニチン、その塩および誘導体の使用
WO2013072767A1 (en) 2011-11-18 2013-05-23 Pronova Biopharma Norge As Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
JP2015524477A (ja) 2012-08-07 2015-08-24 バック・インスティテュート・フォー・リサーチ・オン・エイジング 神経機能を改善するための多成分製剤
US20140107223A1 (en) 2012-10-12 2014-04-17 Whitehill Oral Technologies, Inc. Topical ubiquinol supplement skin care compositions
US20160199337A1 (en) 2013-09-05 2016-07-14 Children's Healthcare Of Atlanta, Inc. Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto
JP2015209398A (ja) 2014-04-25 2015-11-24 ユーハ味覚糖株式会社 高吸収型ユビキノール製剤
CN105519961A (zh) 2014-09-29 2016-04-27 华仁药业股份有限公司 一种用于透析患者的肠内营养制剂及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ＤＡＴＡ 食品の生理活性機能，食品と科学 ４３巻９号 ，第43巻，岸 直邦 株式会社食品と科学社

Also Published As

Publication number Publication date
US20190209507A1 (en) 2019-07-11
US20210353578A1 (en) 2021-11-18
EP3503745A4 (en) 2020-04-01
SE1651259A1 (en) 2018-02-27
SE542106C2 (en) 2020-02-25
EP3503745A1 (en) 2019-07-03
EP3503745B1 (en) 2021-10-27
JP2019532098A (ja) 2019-11-07
US11077085B2 (en) 2021-08-03

Similar Documents

Publication Publication Date Title
Vanek et al. ASPEN position paper: recommendations for changes in commercially available parenteral multivitamin and multi–trace element products
CN103533921B (zh) 用于治疗神经外伤的方法
US20070292493A1 (en) Pharmaceutical composition and method for the transdermal delivery of calcium
US8197854B2 (en) Nutritional supplement for use under physiologically stressful conditions
EP2389077B1 (en) Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health
JPH06504259A (ja) 高コレステロール血症および細胞過増殖性障害の予防および処置用処方および方法
HUP0202342A2 (hu) Esszenciális zsírsavakat és homociszteinszint csökkentő hatóanyagokat tartalmazó gyógyászati és élelmiszer-készítmények
US20240285704A1 (en) Compositions comprising organic mineral chelates, niacinamide, and hemp oil and uses thereof for neuroprotection, cardioprotection, detoxification, immune support, and anti-aging
US20210353578A1 (en) Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
WO2013106570A1 (en) Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers
PT1658079E (pt) Xarope multivitaminico para crianças ou jovens
WO2019165222A1 (en) Dietary macro/micronutritional supplement and applications thereof
WO2018039297A1 (en) Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
US20130064924A1 (en) Nutritional supplement for use under physiologically stressful conditions
WO2010078659A1 (en) Compositions and methods for nutritional prevention and treatment of alzheimer's-associated conditions
CN107106603A (zh) 口服产品
JP2024545938A (ja) ヒトにおけるｒ－ベータ－ヒドロキシブチレートおよび関連化合物の投与
WO2023215815A1 (en) Dietary macro/micronutritional compositions and applications thereof
US7998500B2 (en) Nutritional supplement for women
Siemelink et al. Active components in food supplements
Sriram 8 Micronutrient and

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200821

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200821

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210520

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210915

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220104

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220118

R150 Certificate of patent or registration of utility model

Ref document number: 7012724

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250